• Flash Briefings

  Long-acting Firdapse Development on Track, Flash Briefing

  Posted by Price Wooldridge on April 12, 2021 at 7:00 am

  The ongoing development of Firdapse (amifampridine),which potentially could give us 24 hour coverage with a two dose schedule, is very exciting. It could be of great benefit to those of us who experience LEMS related problems during the overnight period. Here’s my Flash Briefing on it!

  https://soundcloud.app.goo.gl/SdDeiW8xQKBZoRwt7

  Price Wooldridge replied 3 years ago 0 Member · 0 Replies

  • Amifampridine
  • Firdapse
  • Lambert- Eaton Myasthenic Syndrome
  • LEMS
  • treatment
• 0 Replies

Log In to Reply